Stonepine Capital Management, LLC
Q3 2026 13F filing
Updated 9 days ago78 disclosed positions worth $159.4M
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | V VERASTEM INC | $24.5M | 3.04M | 15.37% | — |
| 2 | C CAMP4 THERAPEUTICS CORP | $11.3M | 2.79M | 7.06% | — |
| 3 | E EVOLUS INC | $7.8M | 971.6K | 4.88% | — |
| 4 | A ADMA BIOLOGICS INC | $7M | 700.0K | 4.41% | — |
| 5 | N NEKTAR THERAPEUTICS | $6.7M | 110.0K | 4.18% | — |
| 6 | ? N/A ELOXX PHARMACEUTICALS INC | $5.8M | 382.0K | 3.67% | — |
| 7 | I INSMED INC | $5.6M | 40.0K | 3.51% | — |
| 8 | A ADMA BIOLOGICS INC | $5.2M | 400.0K | 3.26% | — |
| 9 | E EVOLUS INC | $5M | 500.0K | 3.14% | — |
| 10 | Z ZAI LAB LTD | $4.5M | 150.0K | 2.82% | — |
| 11 | E ESTABLISHMENT LABS HLDGS INC | $4.3M | 50.0K | 2.67% | — |
| 12 | M MIRUM PHARMACEUTICALS INC | $4.2M | 40.0K | 2.64% | — |
| 13 | M SATELLOS BIOSCIENCE INC | $3.9M | 455.1K | 2.43% | — |
| 14 | K KAZIA THERAPEUTICS LTD | $3.6M | 377.4K | 2.27% | — |
| 15 | I INDIVIOR PHARMACEUTICALS INC | $3.6M | 100.0K | 2.25% | — |
| 16 | R ULTRAGENYX PHARMACEUTICAL IN | $3.2M | 210.0K | 1.98% | — |
| 17 | R ULTRAGENYX PHARMACEUTICAL IN | $3M | 100.0K | 1.88% | — |
| 18 | ? N/A EDESA BIOTECH INC | $3M | 710.3K | 1.88% | — |
| 19 | A ALUMIS INC | $2.6M | 200.0K | 1.63% | — |
| 20 | B BOSTON SCIENTIFIC CORP | $2.4M | 55.0K | 1.51% | — |
| 21 | A AYTU BIOPHARMA INC | $2.1M | 964.9K | 1.30% | — |
| 22 | ? N/A AN2 THERAPEUTICS INC | $1.9M | 350.9K | 1.17% | — |
| 23 | ? N/A XILIO THERAPEUTICS INC | $1.7M | 189.1K | 1.07% | — |
| 24 | Q PYXIS ONCOLOGY INC | $1.6M | 689.0K | 1.01% | — |
| 25 | A ARDELYX INC | $1.5M | 300.0K | 0.94% | — |
| 26 | A ABEONA THERAPEUTICS INC | $1.5M | 282.0K | 0.93% | — |
| 27 | ? N/A SURROZEN INC | $1.4M | 44.1K | 0.89% | — |
| 28 | A ABEONA THERAPEUTICS INC | $1.4M | 200.0K | 0.88% | — |
| 29 | ? N/A CELLECTAR BIOSCIENCES INC | $1.4M | 749.0K | 0.86% | — |
| 30 | K PASITHEA THERAPEUTICS CORP | $1.4M | 2.77M | 0.86% | — |
| 31 | A ADICET BIO INC | $1.3M | 188.2K | 0.84% | — |
| 32 | I INHIBIKASE THERAPEUTICS INC | $1.3M | 647.3K | 0.83% | — |
| 33 | P PHATHOM PHARMACEUTICALS INC | $1.3M | 100.0K | 0.78% | — |
| 34 | O OKYO PHARMA LTD | $1.2M | 914.4K | 0.74% | — |
| 35 | Q QUOIN PHARMACEUTICALS LTD | $1.2M | 252.4K | 0.72% | — |
| 36 | T TENAX THERAPEUTICS INC | $1.1M | 588.0K | 0.70% | — |
| 37 | J ZEVRA THERAPEUTICS INC | $1.1M | 100.0K | 0.69% | — |
| 38 | J ZEVRA THERAPEUTICS INC | $1.1M | 100.0K | 0.69% | — |
| 39 | C CABALETTA BIO INC | $998K | 520.0K | 0.63% | — |
| 40 | C CODEXIS INC | $941K | 677.0K | 0.59% | — |
| 41 | ? N/A IN8BIO INC | $928K | 697.9K | 0.58% | — |
| 42 | G GOSSAMER BIO INC | $747K | 63.0K | 0.47% | — |
| 43 | X XENON PHARMACEUTICALS INC | $744K | 20.0K | 0.47% | — |
| 44 | ? N/A AZITRA INC | $719K | 5.23M | 0.45% | — |
| 45 | F FEMASYS INC | $706K | 326.8K | 0.44% | — |
| 46 | ? N/A ZENTALIS PHARMACEUTICALS INC | $706K | 254.8K | 0.44% | — |
| 47 | M MOONLAKE IMMUNOTHERAPEUTICS | $702K | 60.0K | 0.44% | — |
| 48 | C CORBUS PHARMACEUTICALS HLDGS | $648K | 95.0K | 0.41% | — |
| 49 | ? N/A AEON BIOPHARMA INC | $638K | 2.13M | 0.40% | — |
| 50 | A ALUMIS INC | $628K | 85.0K | 0.39% | — |